Laurent Boissel

Person

Culver City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-B7-H4 chimeric antigen receptor-modified NK-92 cells
- Patent number 12,180,283
- Issue date Dec 31, 2024
- ImmunityBio, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptor-modified NK-92 cells
- Patent number 12,109,238
- Issue date Oct 8, 2024
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cell-mediated transient delivery of immune-enhancing molecules into...
- Patent number 11,992,504
- Issue date May 28, 2024
- ImmunityBio, Inc.
- John H. Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce m...
- Patent number 11,813,292
- Issue date Nov 14, 2023
- Immunity Bio, Inc.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified NK-92 haNK003 cells for the clinic
- Patent number 11,753,625
- Issue date Sep 12, 2023
- ImmunityBio, Inc.
- Hans Klingemann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fc-epsilon car
- Patent number 11,643,452
- Issue date May 9, 2023
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptor-modified NK-92 cells
- Patent number 11,547,727
- Issue date Jan 10, 2023
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nant cancer vaccine
- Patent number 11,439,697
- Issue date Sep 13, 2022
- NantCell, Inc.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptor-modified NK-92 cells targeting EGFR super...
- Patent number 11,230,699
- Issue date Jan 25, 2022
- ImmunityBio, Inc.
- John H. Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hypoxic NK cells and methods therefor
- Patent number 11,221,328
- Issue date Jan 11, 2022
- NantCell, Inc.
- Patrick Soon-Shiong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coordinated multi-prong cancer therapy
- Patent number 11,207,392
- Issue date Dec 28, 2021
- NantCell Inc.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified NK-92 cells and monoclonal antibodies for the...
- Patent number 11,207,350
- Issue date Dec 28, 2021
- ImmunityBio, Inc.
- Tien Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quadricistronic system comprising a homing receptor and chimeric an...
- Patent number 11,129,850
- Issue date Sep 28, 2021
- ImmunityBio, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Elimination of PD-L1-positive malignancies by PD-L1 chimeric antige...
- Patent number 11,077,143
- Issue date Aug 3, 2021
- NantKwest Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nant cancer vaccine
- Patent number 11,071,774
- Issue date Jul 27, 2021
- NantCell, Inc.
- Patrick Soon-Shiong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quadricistronic system comprising a homing receptor and chimeric an...
- Patent number 11,058,723
- Issue date Jul 13, 2021
- NANTKWEST, INC.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified NK-92 cells and monoclonal antibodies for the...
- Patent number 11,000,550
- Issue date May 11, 2021
- NANTKWEST, INC.
- Tien Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Quadricistronic system comprising a homing receptor and chimeric an...
- Patent number 10,960,024
- Issue date Mar 30, 2021
- NANTKWEST, INC.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified NK-92 haNK003 cells for the clinic
- Patent number 10,801,013
- Issue date Oct 13, 2020
- NANTKWEST, INC.
- Hans Klingemann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified NK-92 haNK003 cells for the clinic
- Patent number 10,774,310
- Issue date Sep 15, 2020
- NANTKWEST, INC.
- Hans Klingemann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Elimination of CD19-positive lymphoid malignancies by CD19-CAR expr...
- Patent number 10,765,701
- Issue date Sep 8, 2020
- NANTKWEST, INC.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically modified NK-92 cells and monoclonal antibodies for the...
- Patent number 10,736,921
- Issue date Aug 11, 2020
- NantKwest, Inc.
- Tien Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically modified NK-92 cells and monoclonal antibodies for the...
- Patent number 10,456,420
- Issue date Oct 29, 2019
- NANTKWEST, INC.
- Tien Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20240366972
- Publication date Nov 7, 2024
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Cell-mediated transient delivery of immune-enhancing molecules into...
- Publication number 20240252540
- Publication date Aug 1, 2024
- ImmunityBio, Inc.
- John H. Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20240238623
- Publication date Jul 18, 2024
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Fc-Receptor CAR Constructs and Cells
- Publication number 20240042023
- Publication date Feb 8, 2024
- ImmunityBio, Inc.
- Laurent H. Boissel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF CD33CAR MODIFIED HIGH AFFINITY NK CELLS (T-HANK) TO REDUCE M...
- Publication number 20240016849
- Publication date Jan 18, 2024
- ImmunityBio, Inc.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
- Publication number 20240010979
- Publication date Jan 11, 2024
- ImmunityBio, Inc.
- Hans Klingemann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FC-EPSILON CAR
- Publication number 20230272042
- Publication date Aug 31, 2023
- ImmunityBio, Inc.
- Laurent H. Boissel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Elimination of BCMA-positive malignancies by CAR expressing NK cells
- Publication number 20230172982
- Publication date Jun 8, 2023
- ImmunityBio, Inc.
- Laurent H. Boissel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nant Cancer Vaccine
- Publication number 20230034802
- Publication date Feb 2, 2023
- NANTCELL, INC.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20220401485
- Publication date Dec 22, 2022
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20220144952
- Publication date May 12, 2022
- NantKwest, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY MODIFIED NK-92 CELLS HAVING A SAFETY SWITCH
- Publication number 20220062343
- Publication date Mar 3, 2022
- ImmunityBio, Inc.
- Tien Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER...
- Publication number 20220025329
- Publication date Jan 27, 2022
- ImmunityBio, Inc.
- John H. Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-2 DEPENDENT NK-92 CELLS WITH STABLE FC RECEPTOR EXPRESSION
- Publication number 20220017594
- Publication date Jan 20, 2022
- NantKwest, Inc.
- Francisco Navarro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC AN...
- Publication number 20210386785
- Publication date Dec 16, 2021
- ImmunityBio, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nant Cancer Vaccine
- Publication number 20210353730
- Publication date Nov 18, 2021
- NANTCELL, INC.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC-EPSILON CAR
- Publication number 20210347850
- Publication date Nov 11, 2021
- ImmunityBio, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ELIMINATION OF PD-L1-POSITIVE MALIGNANCIES BY PD-L1 CHIMERIC ANTIGE...
- Publication number 20210322477
- Publication date Oct 21, 2021
- ImmunityBio, Inc.
- Hans G. Klingemann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMOKINE RESPONSIVE ACTIVATED NATURAL KILLER CELLS WITH SECONDARY...
- Publication number 20210324042
- Publication date Oct 21, 2021
- NantKwest, Inc.
- Nathan SCHOMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ELIMINATION OF PD-L1-POSITIVE MALIGNANCIES BY PD-L1 CHIMERIC ANTIGE...
- Publication number 20210315934
- Publication date Oct 14, 2021
- ImmunityBio, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINED INVASION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING...
- Publication number 20210293787
- Publication date Sep 23, 2021
- NantKwest, Inc.
- Nathan Thomas Schomer
- G01 - MEASURING TESTING
Information Patent Application
Chimeric Antigen Receptor-Modified NK-92 Cells
- Publication number 20210260116
- Publication date Aug 26, 2021
- Laurent H. Boissel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE...
- Publication number 20210236550
- Publication date Aug 5, 2021
- NantKwest, Inc.
- Tien Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER...
- Publication number 20210230547
- Publication date Jul 29, 2021
- NANTKWEST, INC.
- John H. Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC-EPSILON CAR (Very imp commercially - in clinical trial)
- Publication number 20210198342
- Publication date Jul 1, 2021
- NantKwest, Inc.
- Laurent H. Boissel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NK-92 Cells to Stimulate Anti-Cancer Vaccine
- Publication number 20210187024
- Publication date Jun 24, 2021
- NantKwest, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Screening of cell clones expressing polygenic transgenes through no...
- Publication number 20210169931
- Publication date Jun 10, 2021
- NantKwest, Inc.
- Laurent H. Boissel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cell-mediated transient delivery of immune-enhancing molecules into...
- Publication number 20210145879
- Publication date May 20, 2021
- NantKwest, Inc.
- John H. Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC vali...
- Publication number 20210040175
- Publication date Feb 11, 2021
- NantKwest, Inc.
- Hans G. Klingemann
- G01 - MEASURING TESTING
Information Patent Application
USE OF CD33CAR MODIFIED HIGH AFFINITY NK CELLS (T-HANK) TO REDUCE M...
- Publication number 20210038645
- Publication date Feb 11, 2021
- NantKwest, Inc.
- Patrick Soon-Shiong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Laurent Boissel

Person

Patents Grantslast 30 patents

Anti-B7-H4 chimeric antigen receptor-modified NK-92 cells

Chimeric antigen receptor-modified NK-92 cells

Cell-mediated transient delivery of immune-enhancing molecules into...

Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce m...

Modified NK-92 haNK003 cells for the clinic

Fc-epsilon car

Chimeric antigen receptor-modified NK-92 cells

Nant cancer vaccine

Chimeric antigen receptor-modified NK-92 cells targeting EGFR super...

Hypoxic NK cells and methods therefor

Coordinated multi-prong cancer therapy

Genetically modified NK-92 cells and monoclonal antibodies for the...

Quadricistronic system comprising a homing receptor and chimeric an...

Elimination of PD-L1-positive malignancies by PD-L1 chimeric antige...

Nant cancer vaccine

Quadricistronic system comprising a homing receptor and chimeric an...

Genetically modified NK-92 cells and monoclonal antibodies for the...

Quadricistronic system comprising a homing receptor and chimeric an...

Modified NK-92 haNK003 cells for the clinic

Modified NK-92 haNK003 cells for the clinic

Elimination of CD19-positive lymphoid malignancies by CD19-CAR expr...

Genetically modified NK-92 cells and monoclonal antibodies for the...

Genetically modified NK-92 cells and monoclonal antibodies for the...

Patents Applicationslast 30 patents

Chimeric Antigen Receptor-Modified NK-92 Cells

Cell-mediated transient delivery of immune-enhancing molecules into...

Chimeric Antigen Receptor-Modified NK-92 Cells

Fc-Receptor CAR Constructs and Cells

USE OF CD33CAR MODIFIED HIGH AFFINITY NK CELLS (T-HANK) TO REDUCE M...

MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC

FC-EPSILON CAR

Elimination of BCMA-positive malignancies by CAR expressing NK cells

Nant Cancer Vaccine

Chimeric Antigen Receptor-Modified NK-92 Cells

Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells

GENETICALLY MODIFIED NK-92 CELLS HAVING A SAFETY SWITCH

CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER...

IL-2 DEPENDENT NK-92 CELLS WITH STABLE FC RECEPTOR EXPRESSION

QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC AN...

Nant Cancer Vaccine

FC-EPSILON CAR

ELIMINATION OF PD-L1-POSITIVE MALIGNANCIES BY PD-L1 CHIMERIC ANTIGE...

CHEMOKINE RESPONSIVE ACTIVATED NATURAL KILLER CELLS WITH SECONDARY...

ELIMINATION OF PD-L1-POSITIVE MALIGNANCIES BY PD-L1 CHIMERIC ANTIGE...

COMBINED INVASION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING...

Chimeric Antigen Receptor-Modified NK-92 Cells

GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE...

CHIMERIC ANTIGEN RECEPTOR-MODIFIED NK-92 CELLS TARGETING EGFR SUPER...

FC-EPSILON CAR (Very imp commercially - in clinical trial)

NK-92 Cells to Stimulate Anti-Cancer Vaccine

Screening of cell clones expressing polygenic transgenes through no...

Cell-mediated transient delivery of immune-enhancing molecules into...

Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC vali...

USE OF CD33CAR MODIFIED HIGH AFFINITY NK CELLS (T-HANK) TO REDUCE M...